Cited by 105Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and LipoproteinsHeart Failure Treatment and Management

Insulin Resistance and Risk of Incident Heart Failure: Cardiovascular Health Study

Open access
Banerjee, Dipanjan, Biggs, Mary L., Mercer, Laina, Mukamal, Kenneth, Kaplan, Robert, Barzilay, Joshua, Kuller, Lewis, Kizer, Jorge R. +6 more·2013·Circulation: Heart Failure

Abstract

Background—: Patients with heart failure (HF) have higher fasting insulin levels and a higher prevalence of insulin resistance as compared with matched controls. Insulin resistance leads to structural abnormalities in the heart, such as increased left atrial size, left ventricular mass, and alterations in transmitral velocity that can precede the diagnosis of HF. It is not known whether insulin resistance precedes the development of HF or whether the relationship between insulin resistance and HF is present among adults with HF caused by nonischemic heart disease. Methods and Results—: We examined 4425 participants (60% women) from the Cardiovascular Health Study after excluding those with HF, myocardial infarction, or treated diabetes mellitus at baseline. We used Cox proportional hazards models to estimate the relative risk of incident HF associated with fasting insulin measured at study entry. There were 1216 cases of incident HF (1103 without antecedent myocardial infarction) during a median follow-up of 12 years (maximum, 19 years). Fasting insulin levels were positively associated with the risk of incident HF (hazard ratio, 1.10; 95% confidence interval, 1.05–1.15, per SD change) when adjusted for age, sex, race, field center, physical activity, smoking, alcohol intake, high-density lipoprotein-cholesterol, total cholesterol, systolic blood pressure, and waist circumference. The association between fasting insulin levels and incident HF was similar for HF without antecedent myocardial infarction (hazard ratio, 1.10; 95% confidence interval, 1.05–1.15). Measures of left atrial size, left ventricular mass, and peak A velocity at baseline were associated both with fasting insulin levels and with HF; however, additional statistical adjustment for these parameters did not completely attenuate the insulin-HF estimate (hazard ratio, 1.08; 95% confidence interval, 1.03–1.14 per 1-SD increase in fasting insulin). Conclusions—: Fasting insulin was positively associated with adverse echocardiographic features and risk of subsequent HF in Cardiovascular Health Study participants, including those without an antecedent myocardial infarction. Clinical Trial Registration—: URL:http://www.clinicaltrials.gov. Unique identifier: NCT00005133.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circheartfailure.112.000022

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Even in subjects without heart failure, myocardial infarction, and diabetes mellitus, fasting plasma insulin level was positively associated with adverse echocardiographic features, which predispose them to a risk of heart failure.

    “Even in subjects without heart failure, myocardial infarction, and diabetes mellitus, fasting plasma insulin level was positively associated with adverse echocardiographic features, which predispose them to a risk of heart failure [126].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Banerjee, D., Biggs, M. L., Mercer, L., Mukamal, K., Kaplan, R., Barzilay, J., Kuller, L., Kizer, J. R., Djousse, L., Tracy, R., Zieman, S., Lloyd-Jones, D., Siscovick, D., & Carnethon, M.
Affiliations
  • Brigham and Women's Hospital (US)
  • From the Stanford University School of Medicine, Stanford, CA (D.B.); University of Washington, Seattle, WA (M.L.B., L.M., D.S.); Beth Israel Deaconess Medical Center, Boston, MA (K.M.); Albert Einstein College of Medicine, Bronx, NY (R.K.); Kaiser Permanente of Georgia, Tucker, GA (J.B.); University of Pittsburgh, Pittsburgh, PA (L.K.); Weill Cornell Medical College, New York, NY (J.R.K.); Brigham and Women’s Hospital, Harvard Medical School, Boston, MA (L.D.); University of Vermont, Burlington, VT...
  • University of Vermont (US)
Venue
Circulation: Heart Failure
Published
2013-05
Volume
6
Issue
3
Pages
364-370
ISSN
  • 1941-3289 (ISSN-L)
  • 1941-3297
OpenAlex
W2096189508
Cited by
105
References
34
Citations by year
2026: 5 · 2025: 6 · 2024: 19 · 2023: 9 · 2022: 17 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 7 · 2014: 7 · 2013: 2
FWCI
4.30
Type
journal article
Language
en
Open access
Locations
  • Circulation Heart Failure (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (n01hc085082-026, n01hc085081-021, n01hc045133-001, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01hc085085-011, n01hc085083-027, n01hc085080-026, n01hc085086-022, 5r01ag031890-04, n01hc55222-0-0-0, n01hc075150-004, n01hc035129-010)
  • National Institute on Aging (R01-AG-031890, AG 20098, R56AG023629, 1R01AG031890, R01AG020098, AG023629, AG027058, R56AG020098, R01AG023629, R01AG015928, R01AG027058)
  • National Heart, Lung, and Blood Institute (N01-HC-85081, N01HC85085, N01 HC085086, N01HC-85083, N0-1-HC-85239, N01 HC085079, R01HL094555, N01 HC085083, N01HC85082, N01HC‐75150, N01 HC85086, N01 HC085080, HHSN 268200800007C, N01 HC035129, N01HC85080, N01 HC015103, N01 HC55222, HHSN268201200036C, N01HC085082, U01HL080295, N01 HC055222, N01 HC085081, HL080295, R01HL080295, N01 HC075150, N01 HC045133, N01-HC85079, ­N01-HC85084)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
insulin resistance, fasting insulin, heart failure, incident heart failure, non-ischemic heart disease, left atrial size, left ventricular mass, echocardiographic abnormalities, Cardiovascular Health Study, cardiovascular risk factors
MeSH terms
Aged, Female, Heart Atria, Heart Failure, Heart Ventricles, Humans, Insulin, Insulin Resistance, Male, Middle Aged, Myocardial Infarction, Organ Size, Prospective Studies, Incidence, Proportional Hazards Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review